Ihnatovych I, Saddler R, Sule N, Szigeti K
Mol Psychiatry. 2024; 29(4):1020-1032.
PMID: 38200291
PMC: 11176066.
DOI: 10.1038/s41380-023-02389-1.
Valles A, Barrantes F
Cells. 2023; 12(16).
PMID: 37626860
PMC: 10453526.
DOI: 10.3390/cells12162051.
Giovenale A, Ruotolo G, Soriano A, Turco E, Rotundo G, Casamassa A
Front Cell Dev Biol. 2023; 10:1107881.
PMID: 36684422
PMC: 9852989.
DOI: 10.3389/fcell.2022.1107881.
Courties A, Olmer M, Myers K, Ordoukhanian P, Head S, Natarajan P
Ann Rheum Dis. 2023; 82(5):710-718.
PMID: 36627169
PMC: 10101906.
DOI: 10.1136/ard-2022-223470.
Di Lascio S, Fornasari D, Benfante R
Int J Mol Sci. 2022; 23(7).
PMID: 35408823
PMC: 8998457.
DOI: 10.3390/ijms23073463.
Prospective, observational, single-centre cohort study with an independent control group matched for age and sex aimed at investigating the significance of cholinergic activity in patients with schizophrenia: study protocol of the CLASH-study.
Schick B, Barth E, Mayer B, Weber C, Hagemeyer T, Schonfeldt C
BMJ Open. 2021; 11(12):e050501.
PMID: 34930729
PMC: 8689167.
DOI: 10.1136/bmjopen-2021-050501.
Structure, Dynamics, and Ligand Recognition of Human-Specific CHRFAM7A (Dupα7) Nicotinic Receptor Linked to Neuropsychiatric Disorders.
Liu D, de Souza J, Ahmad A, Bronowska A
Int J Mol Sci. 2021; 22(11).
PMID: 34067314
PMC: 8196834.
DOI: 10.3390/ijms22115466.
Effect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury.
Lin M, Huang W, Kabbani N, Theiss M, Hamilton J, Ecklund J
PLoS One. 2021; 16(5):e0251110.
PMID: 33956875
PMC: 8101719.
DOI: 10.1371/journal.pone.0251110.
The human-specific duplicated α7 gene inhibits the ancestral α7, negatively regulating nicotinic acetylcholine receptor-mediated transmitter release.
Martin-Sanchez C, Ales E, Balseiro-Gomez S, Atienza G, Arnalich F, Bordas A
J Biol Chem. 2021; 296:100341.
PMID: 33515545
PMC: 7949125.
DOI: 10.1016/j.jbc.2021.100341.
CHRFAM7A: A human specific fusion gene, accounts for the translational gap for cholinergic strategies in Alzheimer's disease.
Szigeti K, Ihnatovych I, Birkaya B, Chen Z, Ouf A, Indurthi D
EBioMedicine. 2020; 59:102892.
PMID: 32818803
PMC: 7452451.
DOI: 10.1016/j.ebiom.2020.102892.
A VNTR Regulates miR-137 Expression Through Novel Alternative Splicing and Contributes to Risk for Schizophrenia.
Pacheco A, Berger R, Freedman R, Law A
Sci Rep. 2019; 9(1):11793.
PMID: 31409837
PMC: 6692358.
DOI: 10.1038/s41598-019-48141-0.
Transcription of PIK3CD in human brain and schizophrenia: regulation by proinflammatory cytokines.
Hood V, Berger R, Freedman R, Law A
Hum Mol Genet. 2019; 28(19):3188-3198.
PMID: 31211828
PMC: 6859435.
DOI: 10.1093/hmg/ddz144.
iPSC model of CHRFAM7A effect on α7 nicotinic acetylcholine receptor function in the human context.
Ihnatovych I, Nayak T, Ouf A, Sule N, Birkaya B, Chaves L
Transl Psychiatry. 2019; 9(1):59.
PMID: 30710073
PMC: 6358606.
DOI: 10.1038/s41398-019-0375-z.
CHRFAM7A alters binding to the neuronal alpha-7 nicotinic acetylcholine receptor.
Chan T, Williams E, Cohen O, Eliceiri B, Baird A, Costantini T
Neurosci Lett. 2018; 690:126-131.
PMID: 30308236
PMC: 6320298.
DOI: 10.1016/j.neulet.2018.10.010.
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment.
Cameli C, Bacchelli E, De Paola M, Giucastro G, Cifiello S, Collo G
Eur J Hum Genet. 2018; 26(12):1824-1831.
PMID: 30089821
PMC: 6244195.
DOI: 10.1038/s41431-018-0223-2.
A human-specific, truncated α7 nicotinic receptor subunit assembles with full-length α7 and forms functional receptors with different stoichiometries.
Lasala M, Corradi J, Bruzzone A, Esandi M, Bouzat C
J Biol Chem. 2018; 293(27):10707-10717.
PMID: 29784875
PMC: 6036215.
DOI: 10.1074/jbc.RA117.001698.
The current agonists and positive allosteric modulators of 7 nAChR for CNS indications in clinical trials.
Yang T, Xiao T, Sun Q, Wang K
Acta Pharm Sin B. 2017; 7(6):611-622.
PMID: 29159020
PMC: 5687317.
DOI: 10.1016/j.apsb.2017.09.001.
Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor.
Corsi-Zuelli F, Brognara F, Quirino G, Hiroki C, Sobrano Fais R, Del-Ben C
Front Immunol. 2017; 8:618.
PMID: 28620379
PMC: 5449450.
DOI: 10.3389/fimmu.2017.00618.
Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.
Smucny J, Tregellas J
J Psychopharmacol. 2017; 31(7):801-811.
PMID: 28441884
PMC: 5963521.
DOI: 10.1177/0269881117705071.
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders.
Kalkman H, Feuerbach D
Cell Mol Life Sci. 2016; 73(13):2511-30.
PMID: 26979166
PMC: 4894934.
DOI: 10.1007/s00018-016-2175-4.